University of Wisconsin Foundation
Follow13F filer, CIK 1697228, MADISON, WI
University of Wisconsin Foundation reported $118,084,001 across 9 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697228-25-000019
- Period
- 2025-09-30
- Reported value
- $118M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 5
- Sold out
- 1
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| RNAMnew | +289,201 | $12.6M |
| NVDAnew | +55,066 | $10.3M |
| MSFTnew | +19,431 | $10.1M |
| AAPLnew | +39,402 | $10M |
| DYNnew | +517,750 | $6.55M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MDGLreduced | -35,369 | -$16.2M |
| 89BIO INCexited | -1,153,357 | -$11.3M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2025
Share positions as resolved from 13F-HR 0001697228-25-000019, largest first. % of portfolio is the value over $118,084,001, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| PDCCPEARL DIVER CREDIT COMPANY I | 1,459,021 | $24.1M | 20.39% | 0 | Timeline | ||
| NUNU HLDGS LTD | 1,431,951 | $22.9M | 19.41% | 0 | Timeline | ||
| AKROAKERO THERAPEUTICS INC | 328,504 | $15.6M | 13.21% | 0 | Timeline | ||
| RNAMAVIDITY BIOSCIENCES INC | 289,201 | $12.6M | 10.67% | new | Timeline | ||
| NVDANVIDIA CORPORATION | 55,066 | $10.3M | 8.7% | new | Timeline | ||
| MSFTMICROSOFT CORP | 19,431 | $10.1M | 8.52% | new | Timeline | ||
| AAPLAPPLE INC | 39,402 | $10M | 8.5% | new | Timeline | ||
| DYNDYNE THERAPEUTICS INC | 517,750 | $6.55M | 5.55% | new | Timeline | ||
| MDGLMADRIGAL PHARMACEUTICALS INC | 13,007 | $5.97M | 5.05% | -35,369 | Timeline |
Sold out in Q3 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| 89BIO INC89BIO INC | 1,153,357 | $11.3M | shares |
How Q3 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001697228-25-000019 | base | 2025-11-14 | acceptance time not in the bulk data set |